Drug Profile
Metformin/rosuvastatin - BC World Pharm
Alternative Names: BCWP-C001; BCWP_C001Latest Information Update: 28 Aug 2019
Price :
$50
*
At a glance
- Originator BC World Pharm
- Class Antihyperglycaemics; Antihyperlipidaemics; Biguanides; Cardiovascular therapies; Fluorobenzenes; Pyrimidines; Small molecules; Sulfonamides
- Mechanism of Action AMP activated protein kinase stimulants; Gluconeogenesis inhibitors; HMG-CoA reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hyperlipidaemia
Most Recent Events
- 28 Aug 2019 No recent reports of development identified for phase-I development in Hyperlipidaemia(In volunteers) in South Korea (PO)
- 10 Jul 2017 BC World Pharm completes a phase I trial in Hyperlipidaemia (In volunteers) in South Korea (PO) (NCT01992211)
- 01 Dec 2016 BC World Pharm completes a phase I trial in Hyperlipidaemia (In volunteers) in South Korea (PO) (NCT01992211)